Miller Howard Investments Inc Gsk PLC Transaction History

Miller Howard Investments Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 22, 2019	SELL	$38.57 - $42.69 $430,094 - $476,036	-11,151 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$37.8 - $42.69 $124,210 - $140,279	-3,286 Reduced 22.76%	11,151 $426,000
Q3 2018 Oct 29, 2018	SELL	$39.75 - $42.69 $142,106 - $152,616	-3,575 Reduced 19.85%	14,437 $580,000
Q2 2018 Jul 17, 2018	SELL	$39.61 - $42.76 $1.18 Million - $1.28 Million	-29,863 Reduced 62.38%	18,012 $726,000
Q1 2018 Apr 23, 2018	BUY	$36.18 - $40.15 $53,112 - $58,940	1,468 Added 3.16%	47,875 $1.87 Million
Q4 2017 Jan 26, 2018	SELL	$35.34 - $41.9 $53.9 Million - $63.9 Million	-1,524,904 Reduced 97.05%	46,407 $1.65 Million
Q3 2017 Oct 30, 2017	BUY	$39.44 - $41.55 $62 Million - $65.3 Million	1,571,311	1,571,311 $63.8 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.8B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Miller Howard Investments Inc , based on Form 13F filings with the SEC.

Stay updated on Miller Howard Investments Inc with notifications on news.